ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,431Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 36

$1.06M Total Retail Price of All Prescriptions

Rank: 2 out of 36

1,367 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 20,695 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 1,477 1,267 1 8
SIMVASTATIN 1,417 1,241 2 3
METOPROLOL SUCCINATE 1,378 1,211 3 5
PRAVASTATIN SODIUM 1,251 1,112 4 9
AMLODIPINE BESYLATE 1,172 1,013 5 4
ATORVASTATIN CALCIUM 997 861 6 10
METOPROLOL TARTRATE 896 790 7 12
WARFARIN SODIUM 844 741 8 11
CARVEDILOL 796 714 9 1
DIGOXIN 650 576 10 16
DOXAZOSIN MESYLATE 636 603 11 40
CRESTOR 614 553 12 13
FUROSEMIDE 538 463 13 6
HYDROCHLOROTHIAZIDE 464 437 14 15
CLOPIDOGREL 445 396 15 2
NIFEDIPINE ER 414 378 16 29
ISOSORBIDE MONONITRATE ER 408 356 17 14
DIOVAN 407 388 18 18
PLAVIX 324 291 19 7
ISOSORBIDE DINITRATE 312 270 10 20 60
AMIODARONE HCL 290 261 21 22
POTASSIUM CHLORIDE 276 243 22 17
CILOSTAZOL 268 253 23 33
NITROSTAT 258 189 24 27
ATENOLOL 254 233 25 23
RANEXA 234 202 26 24
HYDRALAZINE HCL 224 221 27 37
ISOSORBIDE MONONITRATE 220 196 28 65
LIPITOR 217 188 29 30
CLONIDINE HCL 212 179 30 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 192 150 31 50
DIOVAN HCT 192 158 31 34
NIFEDICAL XL 184 180 33 67
FENOFIBRATE 177 148 34 49
AMLODIPINE BESYLATE-BENAZEPRIL 169 162 35 48
LOSARTAN POTASSIUM 163 136 36 19
BYSTOLIC 160 118 37 20
PANTOPRAZOLE SODIUM 159 147 38 43
ZETIA 140 131 39 25
SPIRONOLACTONE 126 85 40 26
NITROGLYCERIN PATCH 125 103 41 83
BENAZEPRIL HCL 121 99 42 35
BUMETANIDE 119 99 43 86
RAMIPRIL 118 100 44 21
LOVAZA 115 85 45 46
OMEPRAZOLE 110 90 46 31
VERAPAMIL ER 110 96 46 69
TRIAMTERENE-HCTZ 104 104 48 56
KLOR-CON M20 104 101 48 66
BENICAR 96 96 50 51
DILTIAZEM ER 93 88 51 62
TRILIPIX 93 65 51 70
LOSARTAN-HYDROCHLOROTHIAZIDE 92 84 53 47
LOVASTATIN 90 86 54 38
RANITIDINE HCL 86 76 55 75
QUINAPRIL HCL 81 69 56 80
GEMFIBROZIL 81 77 56 91
TRICOR 78 69 58 61
VYTORIN 73 64 59 55
IRBESARTAN 73 73 59 104
EXFORGE 64 64 61 63
PENTOXIFYLLINE 63 47 62 109
NEXIUM 63 36 62 32
MULTAQ 60 60 64 52
PACERONE 58 58 65 89
FOSINOPRIL SODIUM 57 57 66 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.